Aramark US Financials
This page shows Aramark US (ARMK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Thin-margin scale still generates cash, but debt service and steady reinvestment keep the economics tighter than revenue suggests.
Cash conversion is stronger than headline earnings imply: operating cash flow was$727M in FY2024 and$921M in FY2025, both comfortably above net income. With net income only$263M and$326M across those same years, the spread points to a business whose reported profit is compressed by financing and noncash charges even when operating cash is steadier.
This is a scale-driven, low-spread operating model: FY2025 operating margin was only
Near-term liquidity improved as the current ratio moved from 0.8x in FY2024 to 1.3x in FY2025, which reduces immediate balance-sheet strain. But leverage still ended FY2025 at 1.9x debt-to-equity, meaning the company is easier to fund month to month than it is lightly financed overall.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aramark US's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aramark US has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 56/100, indicating healthy but not exceptional operating efficiency. This is up from 4.1% the prior year.
Aramark US's revenue grew 6.4% year-over-year to $18.5B, a solid pace of expansion. This earns a growth score of 58/100.
Aramark US has elevated debt relative to equity (D/E of 1.94), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 12/100, reflecting increased financial risk.
Aramark US's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.
Aramark US has a free cash flow margin of 2.3%, earning a moderate score of 36/100. The company generates positive cash flow after capital investments, but with room for improvement.
Aramark US's ROE of 10.2% shows moderate profitability relative to equity, earning a score of 57/100. This is up from 8.6% the prior year.
Aramark US scores 2.57, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aramark US passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Aramark US generates $2.82 in operating cash flow ($921.0M OCF vs $326.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Aramark US earns $2.2 in operating income for every $1 of interest expense ($791.8M vs $364.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Aramark US generated $18.5B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.
Aramark US's EBITDA was $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.0% from the prior year.
Aramark US reported $326.4M in net income in fiscal year 2025. This represents an increase of 24.3% from the prior year.
Aramark US earned $1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.
Cash & Balance Sheet
Aramark US generated $431.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 44.4% from the prior year.
Aramark US held $439.6M in cash against $6.2B in long-term debt as of fiscal year 2025.
Aramark US paid $0.42 per share in dividends in fiscal year 2025. This represents an increase of 10.5% from the prior year.
Aramark US had 263M shares outstanding in fiscal year 2025. This represents a decrease of 0.4% from the prior year.
Margins & Returns
Aramark US's gross margin was 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.
Aramark US's operating margin was 4.3% in fiscal year 2025, reflecting core business profitability. This is up 0.2 percentage points from the prior year.
Aramark US's net profit margin was 1.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.
Aramark US's ROE was 10.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.5 percentage points from the prior year.
Capital Allocation
Aramark US spent $169.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1079.8% from the prior year.
Aramark US invested $489.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.5% from the prior year.
ARMK Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B+1.6% | $4.8B-4.3% | $5.0B+9.1% | $4.6B+8.1% | $4.3B-6.0% | $4.6B+3.1% | $4.4B+0.9% | $4.4B |
| Cost of Revenue | $4.5B+1.5% | $4.4B-4.7% | $4.6B+8.8% | $4.3B+8.6% | $3.9B-5.6% | $4.2B+3.3% | $4.0B-0.5% | $4.0B |
| Gross Profit | $426.4M+2.5% | $416.2M0.0% | $416.0M+12.4% | $370.1M+2.9% | $359.6M-10.3% | $400.9M+1.0% | $397.0M+18.4% | $335.2M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $74.5M+2.5% | $72.7M-1.7% | $73.9M+12.5% | $65.7M-4.0% | $68.4M-2.8% | $70.4M+7.5% | $65.5M+0.1% | $65.4M |
| Operating Income | $219.7M+1.0% | $217.5M-0.1% | $217.8M+19.3% | $182.6M+4.8% | $174.2M-19.8% | $217.3M-0.7% | $218.8M+35.3% | $161.7M |
| Interest Expense | $1.1M | N/A | N/A | N/A | N/A | N/A | $106.8M+31.0% | $81.5M |
| Income Tax | $35.4M-9.6% | $39.1M+85.5% | $21.1M-12.9% | $24.2M+7.7% | $22.5M-37.1% | $35.8M-4.2% | $37.3M+69.0% | $22.1M |
| Net Income | $102.0M+6.0% | $96.2M+10.4% | $87.1M+21.4% | $71.8M+16.1% | $61.9M-41.4% | $105.6M-13.7% | $122.4M+110.6% | $58.1M |
| EPS (Diluted) | $0.38+5.6% | $0.36 | N/A | $0.27+17.4% | $0.23-41.0% | $0.39 | N/A | $0.22 |
ARMK Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.8B+2.2% | $13.5B+1.8% | $13.3B+0.2% | $13.3B-1.5% | $13.5B+6.2% | $12.7B+0.3% | $12.7B+1.0% | $12.5B |
| Current Assets | $3.7B+3.1% | $3.6B+3.1% | $3.5B-0.2% | $3.5B-8.1% | $3.8B+16.5% | $3.3B-3.3% | $3.4B+2.3% | $3.3B |
| Cash & Equivalents | $475.7M+8.2% | $439.6M-31.2% | $639.1M+27.4% | $501.5M-45.5% | $920.5M+90.1% | $484.1M-28.0% | $672.5M+54.2% | $436.1M |
| Inventory | $453.3M+9.3% | $414.6M-1.0% | $418.8M+6.2% | $394.2M-2.9% | $405.9M+10.7% | $366.7M-5.4% | $387.6M+4.6% | $370.4M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $5.0B+1.8% | $4.9B+0.4% | $4.9B+0.5% | $4.9B+0.9% | $4.8B+2.0% | $4.7B+0.8% | $4.7B+0.8% | $4.6B |
| Total Liabilities | $10.6B+2.2% | $10.3B+1.8% | $10.2B-0.4% | $10.2B-2.6% | $10.5B+8.8% | $9.6B-0.1% | $9.6B+0.3% | $9.6B |
| Current Liabilities | $3.1B+8.2% | $2.9B-19.5% | $3.5B+29.5% | $2.7B-14.0% | $3.2B-9.0% | $3.5B-17.0% | $4.2B+22.0% | $3.5B |
| Long-Term Debt | $6.1B-2.5% | $6.2B+15.6% | $5.4B-14.1% | $6.3B+2.4% | $6.1B+22.7% | $5.0B+15.6% | $4.3B-14.4% | $5.0B |
| Total Equity | $3.3B+2.3% | $3.2B+1.9% | $3.1B+2.1% | $3.1B+2.1% | $3.0B-2.0% | $3.1B+1.4% | $3.0B+3.2% | $2.9B |
| Retained Earnings | $586.3M+13.7% | $515.8M+13.8% | $453.3M+15.1% | $393.7M+12.7% | $349.5M+10.8% | $315.5M+31.6% | $239.7M+66.4% | $144.0M |
ARMK Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $400.3M+151.2% | -$782.2M-166.5% | $1.2B+1433.1% | $76.7M-70.0% | $255.9M+143.6% | -$587.2M-157.5% | $1.0B+626.1% | $140.7M |
| Capital Expenditures | $101.3M-17.1% | $122.2M-14.1% | $142.2M+27.7% | $111.4M-3.8% | $115.8M-3.4% | $119.9M-13.9% | $139.3M+63.6% | $85.1M |
| Free Cash Flow | $299.0M+133.1% | -$904.4M-187.5% | $1.0B+3077.9% | -$34.7M-124.8% | $140.1M+119.8% | -$707.0M-180.1% | $882.3M+1487.4% | $55.6M |
| Investing Cash Flow | -$162.8M-5.9% | -$153.7M | N/A | -$131.7M+47.7% | -$251.6M-9.0% | -$230.8M | N/A | -$89.6M |
| Financing Cash Flow | -$203.2M-127.6% | $735.7M | N/A | -$387.2M-191.3% | $423.9M-34.0% | $642.7M | N/A | $32.4M |
| Dividends Paid | $31.5M0.0% | $31.5M+14.3% | $27.6M+0.2% | $27.5M-1.0% | $27.8M-0.1% | $27.9M+11.2% | $25.0M+0.2% | $25.0M |
| Share Buybacks | $25.1M-39.3% | $41.3M+39.1% | $29.7M-3.9% | $30.9M-61.7% | $80.7M+182.4% | $28.6M+98.5% | $14.4M | $0 |
ARMK Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.7%+0.1pp | 8.6%+0.4pp | 8.2%+0.2pp | 8.0%-0.4pp | 8.4%-0.4pp | 8.8%-0.2pp | 9.0%+1.3pp | 7.7% |
| Operating Margin | 4.5%-0.0pp | 4.5%+0.2pp | 4.3%+0.4pp | 4.0%-0.1pp | 4.1%-0.7pp | 4.8%-0.2pp | 5.0%+1.3pp | 3.7% |
| Net Margin | 2.1%+0.1pp | 2.0%+0.3pp | 1.7%+0.2pp | 1.6%+0.1pp | 1.5%-0.9pp | 2.3%-0.5pp | 2.8%+1.4pp | 1.3% |
| Return on Equity | 3.1%+0.1pp | 3.0%+0.2pp | 2.8%+0.4pp | 2.3%+0.3pp | 2.1%-1.4pp | 3.4%-0.6pp | 4.0%+2.1pp | 2.0% |
| Return on Assets | 0.7%+0.0pp | 0.7%+0.1pp | 0.7%+0.1pp | 0.5%+0.1pp | 0.5%-0.4pp | 0.8%-0.1pp | 1.0%+0.5pp | 0.5% |
| Current Ratio | 1.21-0.1 | 1.27+0.3 | 0.99-0.3 | 1.29+0.1 | 1.21+0.3 | 0.94+0.1 | 0.81-0.2 | 0.96 |
| Debt-to-Equity | 1.85-0.1 | 1.94+0.2 | 1.71-0.3 | 2.030.0 | 2.02+0.4 | 1.61+0.2 | 1.42-0.3 | 1.71 |
| FCF Margin | 6.1%+24.8pp | -18.7%-39.2pp | 20.5%+21.2pp | -0.8%-4.0pp | 3.3%+18.8pp | -15.5%-35.5pp | 20.0%+18.7pp | 1.3% |
Similar Companies
Frequently Asked Questions
What is Aramark US's annual revenue?
Aramark US (ARMK) reported $18.5B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Aramark US's revenue growing?
Aramark US (ARMK) revenue grew by 6.4% year-over-year, from $17.4B to $18.5B in fiscal year 2025.
Is Aramark US profitable?
Yes, Aramark US (ARMK) reported a net income of $326.4M in fiscal year 2025, with a net profit margin of 1.8%.
What is Aramark US's EBITDA?
Aramark US (ARMK) had EBITDA of $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Aramark US have?
As of fiscal year 2025, Aramark US (ARMK) had $439.6M in cash and equivalents against $6.2B in long-term debt.
What is Aramark US's gross margin?
Aramark US (ARMK) had a gross margin of 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Aramark US's operating margin?
Aramark US (ARMK) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Aramark US's net profit margin?
Aramark US (ARMK) had a net profit margin of 1.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Aramark US pay dividends?
Yes, Aramark US (ARMK) paid $0.42 per share in dividends during fiscal year 2025.
What is Aramark US's return on equity (ROE)?
Aramark US (ARMK) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aramark US's free cash flow?
Aramark US (ARMK) generated $431.8M in free cash flow during fiscal year 2025. This represents a 44.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aramark US's operating cash flow?
Aramark US (ARMK) generated $921.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Aramark US's total assets?
Aramark US (ARMK) had $13.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aramark US's capital expenditures?
Aramark US (ARMK) invested $489.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Aramark US's current ratio?
Aramark US (ARMK) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.
What is Aramark US's debt-to-equity ratio?
Aramark US (ARMK) had a debt-to-equity ratio of 1.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Aramark US's return on assets (ROA)?
Aramark US (ARMK) had a return on assets of 2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Aramark US's Altman Z-Score?
Aramark US (ARMK) has an Altman Z-Score of 2.57, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aramark US's Piotroski F-Score?
Aramark US (ARMK) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aramark US's earnings high quality?
Aramark US (ARMK) has an earnings quality ratio of 2.82x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Aramark US cover its interest payments?
Aramark US (ARMK) has an interest coverage ratio of 2.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Aramark US?
Aramark US (ARMK) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.